Moolec Science SA has released its unaudited pro forma condensed combined financial statements, providing insights into the financial aspects following its strategic business combination with Bioceres Group, Gentle Tech, and Nutrecon. This merger and acquisition transaction, formalized on June 16, 2025, has resulted in an expanded company structure with Moolec as the parent entity. The financial statements, prepared under the acquisition method of accounting in accordance with IFRS 3, reflect the historical financial data of Moolec and Bioceres Group. The statements are intended to aid stakeholders in analyzing the financial implications of the business combination, although they do not include potential cost savings or synergies expected post-integration. The pro forma adjustments are based on current information and assumptions, with actual future adjustments potentially differing significantly.